Δ 9-Tetrahydrocannabinol-induced conditioned place preference and intracerebroventricular self-administration in rats

European Journal of Pharmacology

Volumn 506, Issue 1, 2004, Pages 63-69

  Braida, Daniela ^a   Iosuè, Stefania ^a   Pegorini, Simona ^a   Sala, Mariaelvina ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

9 THC; Conditioned place preference; i.c.v. self administration

Indexed keywords

CANNABINOID; CANNABINOID 1 RECEPTOR; CANNABINOID RECEPTOR ANTAGONIST; DRONABINOL; NALOXONE; OPIATE; OPIATE ANTAGONIST; RIMONABANT; DRUG DERIVATIVE; NARCOTIC ANTAGONIST; PIPERIDINE DERIVATIVE; PSYCHOTROPIC AGENT; PYRAZOLE DERIVATIVE; TETRAHYDROCANNABINOL;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG INFUSION; DRUG SELF ADMINISTRATION; EXPERIMENTAL TEST; LABORATORY; LOW DRUG DOSE; MALE; NONHUMAN; PLACE PREFERENCE; PRIORITY JOURNAL; RAT; REWARD; ANIMAL; COMPARATIVE STUDY; DOSE RESPONSE; DRUG ANTAGONISM; INSTRUMENTAL CONDITIONING; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; METHODOLOGY; WISTAR RAT;

ANIMALS; CONDITIONING, OPERANT; DOSE-RESPONSE RELATIONSHIP, DRUG; INJECTIONS, INTRAVENTRICULAR; MALE; NALOXONE; NARCOTIC ANTAGONISTS; PIPERIDINES; PSYCHOTROPIC DRUGS; PYRAZOLES; RATS; RATS, WISTAR; RECEPTOR, CANNABINOID, CB1; SELF ADMINISTRATION; TETRAHYDROCANNABINOL;

EID: 9644255633     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2004.10.043     Document Type: Article

References (44)

1. S. Agurell, M. Halldin, J.E. Lindgren, A. Ohlsson, M. Widman, H. Gillespie, and L. Hollister Pharmacokinetics and metabolism of delta 1-tetrahydrocannabinol and other cannabinoids with emphasis on man Pharmacol. Rev. 38 1986 21 43
2. D. Braida, W. Virag, F. Ottonello, S. Inghilterra, E. Gori, and M. Sala A novel method for self-administering addicting drugs intracerebroventricularly in a free-choice procedure Brain Res. Brain Res. Protoc. 3 1998 135 141
3. D. Braida, M. Pozzi, R. Cavallini, and M. Sala Intracerebral self-administration of the cannabinoid agonist CP 55,940 in the rat: interaction with the opioid system Eur. J. Pharmacol. 413 2001 227 234
4. J.M. Carney, I.M. Uwaydah, and R.L. Balster Evaluation of a suspension system for intravenous self-administration studies of water-insoluble compounds in the rhesus monkey Pharmacol. Biochem. Behav. 7 1977 357 364
5. D. Carriero, J. Aberman, S.Y. Lin, A. Hill, A. Makriyannis, and J.D. Salamone A detailed characterization of the effects of four cannabinoid agonists on operant lever pressing Psychopharmacology 137 1998 147 156
6. A. Castañe, P. Robledo, A. Matifas, B.L. Kieffer, and R. Maldonado Cannabinoid withdrawal syndrome is reduced in double mu and delta opioid receptor knockout mice Eur. J. Neurosci. 17 2003 155 159
7. 1) receptors in the establishment of place conditioning in rats Psychopharmaclogy 135 1998 324 332
8. J.F. Cheer, D.A. Kendall, and A. Marsden Cannabinoid receptors and reward in the rat: a conditioned place preference study Psychopharmacology 151 2000 25 30
9. 1 receptor agonist WIN 55,212-2 in rats Psychopharmacology 156 2001 410 416
10. E. Fride Anandamide: tolerance and cross-tolerance to delta 9-tetrahydrocannabinol Brain Res. 697 1995 83 90
11. E.L. Gardner Addictive potential of cannabinoids: the underlying neurobiology Chem. Phys. Lipids 121 2002 267 290
12. E.L. Gardner, W. Paredes, D. Smith, A. Donner, C. Milling, D. Cohen, and D. Morrison Facilitation of brain stimulation reward by delta-9- tetrahydrocannabinol Psychopharmacology 96 1988 142 144
13. A.G. Gilman G-proteins and dual control of adenylate cyclase Cell 36 1984 577 579
14. R.T. Harris, W. Waters, and D. McLendon Evaluation of reinforcing capability of delta-9-tetrahydrocannabinol in rhesus monkeys Psychopharmacologia 37 1974 23 29
15. 9- tetrahydrocannabinol Br. J. Pharmacol. 125 1998 51 56
16. Z. Justinova, G. Tanda, G.H. Redhi, and S.R. Goldberg Self-administration of delta(9)-tetrahydrocannabinol (THC) by drug naive squirrel monkeys Psychopharmacology 169 2003 135 140
17. S. Kaymakcalan Physiological and psychological dependence on THC in rhesus monkeys W.D.M. Paton J. Crown Cannabis and Its Derivatives 1972 Oxford University Press London 142 149
18. S. Kaymakcalan Tolerance to and dependence on cannabis Bull. Narc. 25 1973 39 47
19. G.F. Koob The reward system and cocaine abuse S.G. Korenman J.D. Barchas Biological Basis of Substance Abuse 1993 Oxford Univ. Press New York 339 354
20. 1 receptor knockout mice Science 283 1999 401 404
21. J.R. Leite, and E.A. Carlini Failure to obtain "cannabis-directed behavior" and abstinence syndrome in rats chronically treated with cannabis sativa extracts Psychopharmacologia 36 1974 133 145
22. 9-tetrahydrocannabinol: comparison with cocaine, morphine, and food reward Life Sci. 56 1995 2073 2080
23. R. Maldonado Study of cannabinoid dependence in animals Pharmacol. Ther. 95 2002 153 164
24. 9-Tetrahydrocannabinol, but not the endogenous cannabinoid receptor ligand anandamide, produces conditioned place avoidance Life Sci. 62 1998 669 677
25. R.S. Mansbach, K.L. Nicholson, B.R. Martin, and R.L. Balster Failure of delta(9)-tetrahydrocannabinol and CP 55,940 to maintain intravenous self-administration under a fixed-interval schedule in rhesus monkeys Behav. Pharmacol. 5 1994 219 225
26. M. Melis, G.L. Gessa, and M. Diana Different mechanisms for dopaminergic excitation induced by opiates and cannabinoids in the rat midbrain Prog. Neuropsychopharmacol. Biol. Psychiatry 24 2000 993 1006
27. M. Navarro, J. Chowen, A. Rocio, M. Carrera, I. del Arco, M.A. Villanua, Y. Martin, A.J. Roberts, G.F. Koob, and F.R. de Fonseca CB1 cannabinoid receptor antagonist-induced opiate withdrawal in morphine-dependent rats NeuroReport 9 1998 3397 3402
28. M. Navarro, M.R. Carrera, W. Fratta, O. Valverde, G. Cossu, L. Fattore, J.A. Chowen, R. Gomez, I. del Arco, M.A. Villanua, R. Maldonado, G.F. Koob, and F. Rodriguez de Fonseca Functional interaction between opioid and cannabinoid receptors in drug self-administration J. Neurosci. 21 2001 5344 5350
29. E.S. Onaivi, R. Green, and B.R. Martin Pharmacological characterization of cannabinoids in the elevated plus-maze J. Pharmacol. Exp. Ther. 253 1990 1002 1009
30. L.A. Parker, and T. Gillies THC-induced place and taste aversions in Lewis and Sprague-Dawley rats Behav. Neurosci. 109 1995 71 78
31. R. Pickens, T. Thompson, and D.C. Muchow Cannabis and phencyclidine self-administered by animals L. Goldfarb F. Hoffmeister Psychic Dependence, Bayer-Symposium IV, Pshychic Dependence 1973 Springer Verlag Berlin 78 86
32. T.E. Robinson, and K.C. Berridge Addiction Annu. Rev. Psychol. 54 2003 25 53
33. F. Rodriguez de Fonseca, P. Rubio, F. Menzaghi, E. Merlo-Pich, J. Rivier, G.F. Koob, and M. Navarro Corticotropin-releasing factor (CRF) antagonist [d-Phe12,Nle21,38,C alpha MeLeu37] CRF attenuates the acute actions of the highly potent cannabinoid receptor agonist HU-210 on defensive-withdrawal behavior in rats J. Pharmacol. Exp. Ther. 276 1996 56 64
34. M. Sala, D. Braida, M. Colombo, A. Groppetti, S. Sacco, E. Gori, and M. Parenti Behavioral and biochemical evidence of opioidergic involvement in cocaine sensitization J. Pharmacol. Exp. Ther. 274 1995 450 457
35. M.C. Sanudo-Peña, K. Tsou, E.R. Delay, A.G. Hohman, M. Force, and J.M. Walzer Endogenous cannabinoids as an aversive or counter-rewarding system in the rat Neurosci. Lett. 21 1997 125 128
36. E. Sulcova, R. Mechoulam, and E. Fride Biphasic effect of anandamide Pharmacol. Biochem. Behav. 59 1998 347 352
37. R.N. Takahashi, and G. Singer Self-administration of delta-9- tetrahydrocannabinol by rats Pharmacol. Biochem. Behav. 11 1979 737 740
38. R.N. Takahashi, and G. Singer Effects of body weight levels on cannabis self-administration Pharmacol. Biochem. Behav. 13 1980 877 881
39. G. Tanda, and S.R. Goldberg Cannabinoids: reward, dependence, and underlying neurochemical mechanisms: a review of recent preclinical data Psychopharmacology 169 2003 115 134
40. 1 opioid receptor mechanism Science 276 1997 2048 2050
41. G. Tanda, P. Munzar, and S.R. Goldberg Self-administration behavior is maintained by the psychoactive ingredient of marijuana in squirrel monkeys Nat. Neurosci. 3 2000 1073 1074
42. 9-tetrahydrocannabinol in mice Psychopharmacology 147 2000 436 438
43. 9-tetrahydrocannabinol and nicotine Br. J. Pharmacol. 135 2002 564 578
44. J.M. Van Ree, J.L. Slangen, and D. De Wied Intravenous self-administration of drugs in rats J. Pharmacol. Exp. Ther. 204 1978 547 557